Video Experimental Relacionado
Updated: Jul 10, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
La medicina, la medicina, la medicina, la medicina, la medicina, la medicina, la medicina, la medicina, la medicina,
John R Marler1, Larry B Goldstein
1National Institute of Neurological Disorders and Stroke, Bethesda, MD 20817, USA. marlerj@ninds.nih.gov
Science (New York, N.Y.)
|September 23, 2003
Resumen
Los resultados de los ensayos clínicos para el activador del plasminógeno tisular (tPA) tardan en llegar a los pacientes con accidente cerebrovascular isquémico agudo. Superar las barreras para el uso de tPA requiere un esfuerzo concertado para obtener mejores resultados para los pacientes.
Área de la Ciencia:
- Neurología Neurología.
- Medicina Cardiovascular La medicina cardiovascular es una especialidad de la salud.
- Política de salud Política de salud
Sus antecedentes:
- La evidencia de ensayos clínicos para tratamientos efectivos no siempre se adopta rápidamente en la atención médica estándar.
- La terapia trombolítica, específicamente el activador de plasminógeno tisular (tPA), ha demostrado eficacia en pacientes seleccionados con accidente cerebrovascular isquémico agudo.
- La brecha entre los resultados de la investigación y la práctica clínica puede retrasar el beneficio para el paciente.
Objetivo del estudio:
- Identificar y describir las barreras que impiden la adopción generalizada de la terapia trombolítica (tPA) en el manejo del accidente cerebrovascular isquémico agudo.
- Informar estrategias para superar estos obstáculos y mejorar el acceso de los pacientes a un tratamiento oportuno.
Principales métodos:
- Este Foro de Políticas sintetiza la literatura existente y las opiniones de expertos.
- Análisis de los factores que influyen en la implementación de intervenciones de ictus basadas en la evidencia.
Principales resultados:
- Varias barreras impiden el uso rutinario de tPA para el accidente cerebrovascular isquémico agudo.
- Estos incluyen factores relacionados con los sistemas de atención médica, la práctica profesional y la concienciación del paciente.
Conclusiones:
- Las barreras para el uso de tPA son identificables y direccionables.
- Es necesario un enfoque coordinado y multifacético para acelerar la integración de tPA en los protocolos de ACV isquémico agudo.
Videos de Conceptos Relacionados
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:26Transient Ischemic Attack l: Introduction
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
01:28Traumatic Brain Injury l: Introduction
DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...